Ad-hCMV-Flt3L

A human serotype 5, replication-defective, first generation adenoviral vector, with the viral E1a and E3 protein encoding regions deleted, which is engineered to express the soluble, immune-mediated stimulatory gene human fms-like tyrosine kinase 3 ligand (Flt3L), under the transcriptional control of the CMV promoter, with potential immunostimulating activity. Upon administration, Ad-hCMV-Flt3L is transduced into tumor cells and Flt3L is expressed. Flt3L stimulates both the proliferation of dendritic cells (DCs) and their migration to the tumor site. Upon exposure to the tumor-associated antigens (TAA) released from dying glioma cells, which were killed by thymidine kinase-mediated valacyclovir-induced tumor cell death, the DCs initiate a specific immune response against any remaining TAA-expressing tumor cells. Flt3L is a hematopoietic growth factor and ligand for the Flt3 tyrosine kinase receptor. (NCI Thesaurus)

YOU MAY ALSO LIKE

AD Term Type

The NCI term type designation for the adjectival form of a noun.

AD Regimen

A regimen consisting of doxorubicin and dacarbazine used for the treatment of unresectable soft tissue sarcoma.

AD 32

A drug used to treat bladder cancer that does not respond to BCG (Bacillus Calmette Guerin). It is an anthracycline and is…

Aczone Gel

Other name for dapsone gel, 5%.

Aczone

Other name for dapsone.

Acyltransferase

Class of enzymes that catalyze the transfer of acyl groups, most commonly a carboxylic acyl group forming either esters or amides. …